#1
#1 out of 1
health1d ago
SGMC Health Offers New Treatment Option for Early Alzheimer’s Disease - SGMC Health
- SGMC Health offers an FDA-approved anti-amyloid infusion therapy for early Alzheimer’s disease at SGMC Neurology.
- The therapy is delivered through regular IV infusions aimed at removing substances linked to Alzheimer’s progression.
- Early treatment may help patients maintain independence and daily routines longer.
- Patients must complete several evaluations before starting therapy to ensure safety and suitability.
- Ideal candidates are in the earliest Alzheimer’s stages with memory or thinking changes.
- A neurology team guides patients and families through results and decisions.
- SGMC emphasizes shared decision-making and ongoing monitoring during treatment.
- The treatment is one of the first to slow disease progression rather than just relieve symptoms.
- Patients and families are urged to contact SGMC Neurology for guidance and next steps.
- The update appears in SGMC Health communications and related categories.
Vote 0